Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
July 31, 2024 3.812M
April 30, 2024 3.432M
January 31, 2024 3.810M
October 31, 2023 3.284M
July 31, 2023 3.223M
April 30, 2023 3.190M
January 31, 2023 3.294M
October 31, 2022 5.180M
July 31, 2022 3.217M
April 30, 2022 3.974M
January 31, 2022 3.345M
October 31, 2021 3.138M
July 31, 2021 2.857M
April 30, 2021 2.101M
January 31, 2021 1.915M
October 31, 2020 1.886M
July 31, 2020 1.829M
April 30, 2020 2.406M
January 31, 2020 1.849M
October 31, 2019 1.301M
July 31, 2019 1.269M
April 30, 2019 1.039M
January 31, 2019 1.589M
October 31, 2018 0.6617M
July 31, 2018 0.5814M
Date Value
April 30, 2018 0.5488M
January 31, 2018 0.544M
October 31, 2017 0.3764M
July 31, 2017 0.3895M
April 30, 2017 0.0721M
January 31, 2017 0.1328M
October 31, 2016 0.00
July 31, 2016 0.3202M
April 30, 2016 0.5339M
January 31, 2016 0.4984M
October 31, 2015 0.4789M
July 31, 2014 0.3699M
April 30, 2014 0.3016M
January 31, 2014 0.2832M
October 31, 2013 0.2441M
July 31, 2013 0.1457M
April 30, 2013 0.4392M
January 31, 2013 0.4379M
October 31, 2012 0.3872M
July 31, 2012 0.3894M
April 30, 2012 0.4203M
January 31, 2012 0.069M
October 31, 2011 0.0666M
July 31, 2011 0.0649M
April 30, 2011 0.0514M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Bespoke Extracts, Inc. 2.891M
Carisma Therapeutics, Inc. 7.421M
Windtree Therapeutics, Inc. 27.58M
IDEXX Laboratories, Inc. 1.830B
Neogen Corp. 1.301B